Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Mar;15(3):382–388. doi: 10.1016/j.bbmt.2008.12.494

Figure 4. Suppressive activity of CD4+CD25+ Treg following IL-2 and CD4+ DLI combined therapy.

Figure 4

Suppressive activity of purified CD4+CD25+ T cells was assessed for patients 1, 2, 3 and 5 using samples collected after DLI and during IL-2 treatment. Suppression by Treg purified from 4 healthy donors was also measured. Solid lines represent median values for the 2 groups.